Unity Biotechnology, Inc. (UBX)
Market Closed
8 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 20
+0.1
+92.7746%
$
3.44M Market Cap
- P/E Ratio
- Div Yield
3.36M Volume
-3.43 Eps
$ 0.1
Previous Close Want to track UBX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Unity Biotechnology, Inc. (UBX) Statistics
Valuation metrics
Market Cap 3.44M
Enterprise value 18.05M
Trailing P/E (ttm) -0.21
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 2.59
Price/Book (mrq) -16.47
Enterprise Value/Revenue 13.59
Enterprise Value/EBITDA -1.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.1
52-Week high 3.1
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 20 Oct 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -11.85%
Operating margin -10.72%
Operational effectiveness
Return on assets -0.52%
Return on equity -5.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.08
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.93
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1
Total debt (mrq) -
Total Debt/Equity (mrq) -110.28
Current ratio (mrq) 1.95%
Book value per share (mrq) -0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
